Basak E Uygun

Dr. Basak E Uygun


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2010 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
BUBasak E Uygun
Basak E Uygun
ASAlejandro Soto-Gutierrez
Alejandro Soto-Gutierrez
HYHiroshi Yagi
Hiroshi Yagi
MIMaria-Louisa Izamis
Maria-Louisa Izamis
MGMaria A Guzzardi
Maria A Guzzardi
KUKorkut Uygun
Korkut Uygun

1 June 2012 in Journal of Surgical Research
Verified
Journal Article
Closed access
HTHerman Tolboom
Herman Tolboom
MIMaria-Louisa Izamis
Maria-Louisa Izamis
NSNripen Sharma
Nripen Sharma
JMJack M. Milwid
Jack M. Milwid
BUBasak E Uygun
Basak E Uygun
MYMartin L. Yarmush
Martin L. Yarmush

1 November 2009 in Tissue Engineering Part A
Verified
Journal Article
Closed access
BUBasak E Uygun
Basak E Uygun
SSSarah E. Stojsih
Sarah E. Stojsih
Howard MatthewHoward Matthew
Howard Matthew
Mesenchymal stem cells (MSCs) are adult stem cells with potential for multilineage differentiation. They represent an attractive cell source alternative to embryonic stem cells for therapeutic applications. Optimal utilization of MSCs for tissue engineering requires improved biomaterials that can enhance their growth and direct differentiation. The biological activity of glycosaminoglycans (GAGs) has been previously exploited for use in tissue engineering applications. In this study, MSC proliferation and differentiation was studied on GAG-derivatized chitosan membranes. The GAGs included heparin, heparan sulfate, dermatan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate, and hyaluronic acid. The covalent GAG immobilization method and amount of immobilized GAG were varied. It was found that MSC growth increased as much as fivefold on GAG-immobilized surfaces compared to tissue culture plastic and chitosan-only controls. The MSC growth rates increased significantly with increasing GAG density on the culture surfaces. The MSC proliferation rates on heparin, heparan sulfate, dermatan sulfate, and chondroitin 6-sulfate exhibited nonlinear increases with the level of fibronectin binding on these surfaces. In contrast, MSC proliferation on hyaluronic acid and chondroitin 4-sulfate was found to be independent of fibronectin or vitronectin binding on the surfaces, suggesting that these GAGs influenced MSC proliferation through different mechanisms. In conclusion, the results indicate that GAG immobilization on chitosan scaffolds provides an effective means of manipulating MSC proliferation and has promising potential for directing MSC differentiation in tissue engineering applications employing chitosan.

1 September 2018 in Acta Biomaterialia
Verified
Journal Article
Closed access
JDJulie Devalliere
Julie Devalliere
YCYibin Chen
Yibin Chen
KDKevin Dooley
Kevin Dooley
MYMartin L. Yarmush
Martin L. Yarmush
BUBasak E Uygun
Basak E Uygun

14 August 2012 in Nature Reviews Gastroenterology & Hepatology
Verified
Journal Article
Open access
PDF file
BUBasak E Uygun
Basak E Uygun
MYMartin L. Yarmush
Martin L. Yarmush
KUKorkut Uygun
Korkut Uygun
Whole-organ tissue engineering could help address the shortage of donor livers by using damaged organs that would otherwise be rejected for transplantation. In this Perspectives article, Uygun and colleagues outline progress in the decellularization and recellularization of damaged livers and describe the next steps needed for whole-organ tissue engineering to be applied in a clinical setting. Initially hailed as the ultimate solution to organ failure, engineering of vascularized tissues such as the liver has stalled because of the need for a well-structured circulatory system that can maintain the cells seeded inside the construct. A new approach has evolved to overcome this obstacle. Whole-organ decellularization is a method that retains most of the native vascular structures of the organ, providing microcirculatory support and structure, which can be anastomosed with the recipient circulation. The technique was first applied to the heart and then adapted for the liver. Several studies have shown that cells can be eliminated, the extracellular matrix and vasculature are reasonably preserved and, after repopulation with hepatocytes, these grafts can perform hepatic functions in vitro and in vivo. Progress is rapidly being made as researchers are addressing several key challenges to whole-organ tissue engineering, such as ensuring correct cell distribution, nonparenchymal cell seeding, blood compatibility, immunological concerns, and the source of cells and matrices.

21 January 2018 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
MJMaria Jaramillo
Maria Jaramillo
HYHeidi Yeh
Heidi Yeh
MYMartin L. Yarmush
Martin L. Yarmush
BUBasak E Uygun
Basak E Uygun